Defence

Sather Financial Group Inc Increases Stake in UnitedHealth Group Incorporated (NYSE:UNH)


Sather Financial Group Inc increased its stake in UnitedHealth Group Incorporated (NYSE:UNHGet a rating) by 1.7% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,601 shares of the healthcare conglomerate’s stock after purchasing an additional 27 shares during the period. Sather Financial Group Inc.’s holdings in UnitedHealth Group were worth $822,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also made changes to their positions in the company. Advocacy Wealth Management Services LLC boosted its position in shares of UnitedHealth Group by 75.8% in the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 25 shares in the last quarter. Cascade Investment Advisors Inc. grew its position in shares of UnitedHealth Group by 100.0% in the first quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 30 shares in the last quarter. Rothschild & Co Wealth Management UK Ltd acquired a new stake in shares of UnitedHealth Group in the second quarter worth about $31,000. Evolution Advisers Inc. acquired a new stake in shares of UnitedHealth Group in the first quarter worth about $38,000. Finally, Rise Advisors LLC bought a new stake in UnitedHealth Group during the fourth quarter worth about $38,000. Currently, 87.25% of the shares are owned by hedge funds and other institutional investors.

UnitedHealth Group shares fell 0.7%

Actions NYSE:UNH opened at $505.04 on Friday. UnitedHealth Group Incorporated has a 52-week low of $383.12 and a 52-week high of $553.29. The stock has a market cap of $472.40 billion, a P/E ratio of 26.37, a price-to-earnings ratio of 1.59 and a beta of 0.76. The business’s 50-day moving average is $528.35, and its 200-day moving average is $513.52. The company has a gearing ratio of 0.77, a current ratio of 0.77, and a debt-to-equity ratio of 0.60.

UnitedHealth Group (NYSE:UNHGet a rating) last published its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 EPS for the quarter, topping analysts’ consensus estimates of $5.24 by $0.33. The company had revenue of $80.33 billion for the quarter, compared to analyst estimates of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a return on equity of 5.95%. UnitedHealth Group’s revenue rose 12.6% year-over-year. For the same quarter of the previous year, earnings per share amounted to $4.70. sell-side analysts forecast that UnitedHealth Group Incorporated will post 21.86 earnings per share for the current year.

UnitedHealth Group announces dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th were paid a dividend of $1.65 per share. The ex-dividend date of this dividend was Friday, September 9th. This represents an annualized dividend of $6.60 and a yield of 1.31%. UnitedHealth Group’s dividend payout ratio is currently 34.46%.

Insiders make bets

In other SAO news Thomas E. Roos sold 465 shares of the stock in a transaction on Friday, August 26th. The shares were sold at an average price of $542.37, for a total transaction amounting to $252,202.05. Following the completion of the sale, the chief accounting officer now owns 34,786 shares in the company, valued at approximately $18,866,882.82. The sale was disclosed in a document filed with the SEC, which is available via SEC website. In other news, CAO Thomas E. Roos sold 465 shares of the stock in a transaction on Friday, August 26th. The shares were sold at an average price of $542.37, for a total transaction amounting to $252,202.05. Following the completion of the sale, the chief accounting officer now owns 34,786 shares in the company, valued at approximately $18,866,882.82. The sale was disclosed in a document filed with the SEC, which is available via SEC website. Also the director Stephen J. Hemsley sold 99,312 shares of the stock in a transaction on Tuesday, July 26th. The shares were sold at an average price of $534.27 for a total value of $53,059,422.24. Following the sale, the director now owns 787,372 shares in the company, valued at approximately $420,669,238.44. Disclosures for this sale can be found here here. Insiders have sold a total of 139,051 shares of company stock valued at $74,450,958 over the last 90 days. Company insiders own 0.40% of the company’s stock.

Wall Street analysts predict growth

UNH has been the subject of several analyst reports. Loop Capital initiated coverage on UnitedHealth Group in a research note on Thursday, June 16th. They set a “buy” rating and a $575.00 target price on the stock. Credit Suisse Group upped their target price on UnitedHealth Group from $575.00 to $579.00 and gave the stock an “outperform” rating in a research note on Monday, July 18th. Raymond James upped their target price on UnitedHealth Group from $620.00 to $635.00 and gave the stock a “strong-buy” rating in a research note on Thursday, September 22nd. SVB Leerink boosted their target price on UnitedHealth Group from $600.00 to $625.00 and gave the company an “outperform” rating in a research note on Monday, July 18th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on UnitedHealth Group from $556.00 to $569.00 and gave the company a “buy” rating in a research note on Thursday, September 8th. Three analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have issued a strong buy rating to the company. The company presently has a consensus rating of “Moderate Buy” and a consensus target price of $586.40, according to MarketBeat.

About UnitedHealth Group

(Get a rating)

UnitedHealth Group Incorporated operates as a diversified healthcare company in the United States. It operates in four segments: UnitedHealthcare, Optum Health, Optum Insight and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health care plans and services for national employers, public sector employers, mid-sized employers, small businesses and individuals; health care coverage and wellness services for people age 50 and older that meet their needs for preventive and emergency health care, as well as services related to chronic diseases and other specialized problems for older adults; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.

See also

Want to know what other hedge funds hold UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet a rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)



Get UnitedHealth Group news and ratings daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies MarketBeat.com’s FREE Daily E-Newsletter.

https://www.defenseworld.net/2022/10/02/sather-financial-group-inc-increases-holdings-in-unitedhealth-group-incorporated-nyseunh.html Sather Financial Group Inc Increases Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Back to top button